BRAF and nemaline myopathy: NM patients had a significantly shorter median DMFS compared with SSM patients when adjusting for Breslow thickness, BRAF-status, mitotic rate, and ulceration, respectively, that is, 1.9 years (95% CI 1.7–2.1) and 3.1 years (95% CI 2.9–3.3) (p < 0.01) (Kaplan Meier DMFS analysis, Figure S1 and Cox regression DMFS analysis, Table S1, are displayed in the Supplementary Materials).